Deccan Health Care Peer Comparison

BSE: 542248

₹11.70

₹0.05 (0.43%)

As on 28-Sep-2026 14:48IST

Market cap

₹29 Cr

Revenue (TTM)

₹82 Cr

P/E Ratio

11.6

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	29	21,544	19,888	18,158	17,170
Revenue (₹ Cr)	82	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	2.54	678.07	273.51	735.15	666.92
Net Margin (%)	3.11	28.10	16.19	26.88	20.60
RoE (%)	2.32	19.73	11.15	19.16	18.75
Price to Earnings	11.59	32.38	66.89	24.70	26.66
Price-To-Book	0.27	5.87	7.40	4.12	4.26

Income Statement (₹ Cr)

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	81.83	2,287.33	1,682.47	2,569.77	3,229.67
Total Income	81.86	2,413.29	1,689.83	2,735.39	3,237.12
Total Expenditure	76.59	1,490.75	1,203.91	1,628.14	2,090.06
EBITDA	5.24	796.58	478.55	941.63	1,139.61
Depreciation	1.44	78.10	126.01	57.58	281.06
EBIT	3.80	718.48	352.55	884.05	858.55
Interest	0.51	0.88	52.11	7.69	190.64
Other Income	0.03	125.96	7.37	165.62	7.45
Exceptional Items	0.00	0.00	12.16	-49.16	-17.24
Profit before Tax	3.32	843.56	319.96	992.82	658.12
Provision for Tax	0.78	165.49	46.45	257.67	-8.80
Profit after Tax	2.54	678.07	273.51	735.15	666.92

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	110.26	3,586.42	2,591.20	4,202.90	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	4.60	28.74	266.35	91.50	1,392.75
Current Liabilities	34.05	385.94	848.06	627.48	2,077.10
Total Liabilities	124.93	3,207.85	3,310.68	4,911.11	6,865.52

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	15.02	1,291.22	2,525.44	770.28	5,617.77
Current Assets	129.73	2,585.66	1,109.77	3,803.22	1,539.85
Total Assets	124.93	3,207.85	3,310.68	4,911.11	6,865.52
Total Debt*	1.15	0.55	586.37	2.50	2,421.66
Net Current Assets	95.68	2,199.72	261.71	3,175.74	-537.25
Contingent Liabilities	16.77	0.64	76.22	363.79	51.96

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	-6.43	432.37	132.27	659.75	1,065.01
Cash Flow from Investing Activities	-0.14	-334.73	-199.13	-71.34	-79.97
Cash from Financing Activities	7.52	-38.32	62.65	-205.34	-881.32
Net Cash Inflow / Outflow	0.95	59.32	-4.21	383.07	103.72

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	1.65	26.22	6.95	26.21	13.59
ROE (%)	2.32	19.73	11.15	19.16	18.75
ROA (%)	1.86	18.69	7.80	14.95	9.26
EBIT Margin (%)	4.64	31.41	20.95	34.40	26.58
Net Margin (%)	3.11	28.10	16.19	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	-0.37	15.01	27.91	10.69	9.59
EBIT Growth (%)	147.01	18.45	58.32	24.14	16.84
Net Profit Growth (%)	146.51	19.61	149.56	-9.09	62.68
EPS Growth (%)	124.86	17.73	-3.57	14.40	67.41
Book Value Growth (%)	10.15	23.77	30.63	17.30	10.19

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	11.18	32.40	70.65	23.75	26.48
Price / Book Value	0.26	5.87	7.37	4.16	4.34
Dividend Yield (%)	0.00	0.28	0.06	1.87	0.00
EV/EBITDA	5.04	25.80	42.66	16.16	17.32
Market Cap (₹ Cr)	39.68	15,219.80	6,484.12	18,318.10	19,292.77

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.02	0.00	0.07	0.00	0.24
Short term debt to equity ratio	--	0.00	0.13	0.00	0.14
Current Ratio	3.81	6.70	1.31	6.06	0.74
Quick Ratio	2.43	5.59	0.88	5.31	0.53
Interest Coverage	7.58	959.59	7.14	130.11	4.45

	Deccan Health Care	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	20.76	36.10	30.84	7.07	21.07
Asset Turnover	0.60	0.63	0.48	0.52	0.45
Receivable days	54.52	110.70	118.15	29.10	54.06
Inventory Days	214.70	65.86	98.29	69.53	32.16
Payable days	50.95	105.88	128.16	76.77	140.91
Cash Conversion Cycle	218.27	70.68	88.28	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.